CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Exploring CAR T-Cell Therapy for DLBCL
This chapter examines the safety and tolerability of T-cell activating therapies, focusing on CAR T-cell therapy for diffuse large B-cell lymphoma. Through a detailed case study, it discusses treatment options and decision-making criteria for selecting appropriate therapies in patients with refractory disease.
Transcript
Play full episode
